Enhanced CRISPR/Cas-Based Immunoassay through Magnetic Proximity Extension and Detection

Area of Science:

• Biotechnology
• Molecular Diagnostics
• Immunoassays

Background:

• Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas systems are vital for nucleic acid detection.
• Protein detection is crucial for disease diagnosis (e.g., cancer, Alzheimer's) but current methods lack sensitivity.

Purpose of the Study:

• To develop an enhanced CRISPR/Cas-based immunoassay for highly sensitive protein detection.
• To overcome the sensitivity limitations (femtomolar to picomolar range) of existing CRISPR/Cas immunoassays.

Main Methods:

• CRISPR-AMPED combines proximity extension assay (PEA) with magnetic beads to convert proteins into DNA barcodes.
• Isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) and CRISPR/Cas12a detects DNA barcodes, replacing traditional PCR.
• Effective washing steps minimize non-specific binding, reducing background noise.

Main Results:

• CRISPR-AMPED achieved attomolar level sensitivity, exceeding ELISA by over three orders of magnitude.
• The method demonstrated superior performance compared to existing CRISPR/Cas-based detection systems.
• A smartphone-based detection device was developed, showing potential for point-of-care applications.

Conclusions:

• CRISPR-AMPED offers a significant advancement in protein detection sensitivity and potential for point-of-care diagnostics.
• The integration of PEA, magnetic beads, and CRISPR/Cas12a-NAAT provides a powerful platform for sensitive protein quantification.
• This technology has broad implications for medical diagnostics, biological research, and the food industry.